Secretion of VEGF-A facilitated by the ROS/HIF-1α axis was shown to cause resistance to etoposide and doxorubicin [106,107], presumably via mechanisms related to improved vascular stability of the tumour [71]. Here, HIF1A is linked to neoplasm.